Cognition and Depression: An Intricate Link Web Activities - Module 2 (Katherine E. Burdick, PhD)
Jointly provided by Postgraduate Institute for Medicine, Global Medical Education, and HealthmattersCME.
Supported by an independent educational grant from Takeda Pharmaceuticals International, Inc., US Region and Lundbeck Pharmaceutical Services, LLC.
Scroll to the Bottom of this Information to Begin This Course
Release date: August 1, 2014
Valid through: July 31, 2015
Estimated Time to Complete Activity: 60 minutes
This activity has been designed to meet the educational needs of physicians, physician assistants, and nurse practitioners involved in the care of patients with mental illness.
Upon completion of this activity, participants should be better able to:
- Identify cognitive dysfunction in patients with untreated and treated MDD by the use of screening questions and scales
- Help clinicians identify the factors contributing to poor prognosis in MDD patients, including residual cognitive symptoms
- Implement strategies to treat MDD to remission of all symptom domains
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Katherine E. Burdick, PhD
Associate Professor of Psychiatry and
Neuroscience Icahn School of Medicine
at Mount Sinai Neuropsychologist
New York, NY
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine, Global Medical Education, and HealthmattersCME. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
- Consulting Fees: Dainippon Sumitomo Pharma
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Prakash Masand, MD
Consulting Fees: Astra Zeneca; Eli Lilly; Forest Pharmaceuticals; Lundbeck Pharmaceutical Services, LLC; Merck; Pfizer; Sunovion Pharmaceuticals
Fees for Non-CME Services: Eli Lilly; Forest Pharmaceuticals; Merck; Pfizer; Sunovion Pharmaceuticals
James Murphy reported that he does not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, MSN, RN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Instructions for Participation and Credit
There are no fees for participating and receiving credit for this activity. During the period August 1 2014 through July 31, 2015, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and the evaluation form.
To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on Submit Post-test at the bottom of the page. Your post-test will automatically be graded.
If you successfully complete the post-test (score of 70% or higher), your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you receive a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.
Hardware and Software Requirements
A modern web browser is required (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.
This site is best viewed with an HTML5 compatible browser, this list includes the versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.